Revision LR Femoral Stem for Hip Replacement

NCT05810584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2024-04-19

No results posted yet for this study

Summary

This is a post-market, monocentric Retrospective and prospective, observational, open-label and baseline clinical study in order to evaluate the performance and safety of Revision LR femoral stem

Conditions

  • Hip Arthropathy
  • Orthopedic Disorder

Interventions

DEVICE

Revision LR femoral stem

Revision LR is a modular femoral stem used for hip replacement

Sponsors & Collaborators

  • Limacorporate S.p.a

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2024-04-08
Completion
2024-04-08

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05810584 on ClinicalTrials.gov